(Q36906003)

17 August 2017

1 reference

title

Small-vessel vasculitis: therapeutic management (English)

1 reference

17 August 2017

Carol A Langford

1

1 reference

17 August 2017

publication date

1 August 2007

1 reference

Current Rheumatology Reports

17 August 2017

published in

1 reference

17 August 2017

volume

9

1 reference

17 August 2017

issue

4

1 reference

17 August 2017

page(s)

328-335

1 reference

Wegener's Granulomatosis: Prospective Clinical and Therapeutic Experience With 85 Patients for 21 Years

17 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11926-007-0052-8

Wegener Granulomatosis: An Analysis of 158 Patients

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11926-007-0052-8

Are there different forms of life in the antineutrophil cytoplasmic antibody universe?

21 January 2018

1 reference

12 December 2020

Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity

1 reference

12 December 2020

Cyclosporin A therapy for Wegener's granulomatosis

1 reference

12 December 2020

Clinical features and therapeutic management of subglottic stenosis in patients with Wegener's granulomatosis

1 reference

12 December 2020

A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener's granulomatosis

1 reference

12 December 2020

Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients

1 reference

12 December 2020

Mycophenolate mofetil in anti-neutrophil cytoplasm antibodies-associated systemic vasculitis

1 reference

12 December 2020

Interferon-alpha treatment of four patients with the Churg-Strauss syndrome

1 reference

12 December 2020

Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody-associated vasculitis

1 reference

12 December 2020

15-Deoxyspergualin and cyclophosphamide, but not mycophenolate mofetil, prolong survival and attenuate renal disease in a murine model of ANCA-associated crescentic nephritis

1 reference

12 December 2020

Rituximab for refractory Wegener's granulomatosis: report of a prospective, open-label pilot trial

1 reference

12 December 2020

Current state of tumour necrosis factor {alpha} blockade in Wegener's granulomatosis.

1 reference

12 December 2020

Induction of remission in active anti-neutrophil cytoplasmic antibody-associated vasculitis with mycophenolate mofetil in patients who cannot be treated with cyclophosphamide

1 reference

12 December 2020

Prospective study of TNFalpha blockade with infliximab in anti-neutrophil cytoplasmic antibody-associated systemic vasculitis

1 reference

12 December 2020

Response of Wegener's granulomatosis to anti-CD20 chimeric monoclonal antibody therapy

1 reference

12 December 2020

A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies

1 reference

12 December 2020

Plasmapheresis therapy for diffuse alveolar hemorrhage in patients with small-vessel vasculitis

1 reference

12 December 2020

Treatment of refractory Wegener's granulomatosis with antithymocyte globulin (ATG): an open study in 15 patients

1 reference

12 December 2020

High rate of renal relapse in 71 patients with Wegener's granulomatosis under maintenance of remission with low-dose methotrexate

1 reference

12 December 2020

Successful use of rituximab in a patient with recalcitrant Churg-Strauss syndrome

1 reference

12 December 2020

Etanercept plus standard therapy for Wegener's granulomatosis

1 reference

12 December 2020

Mycophenolate mofetil for maintenance therapy of Wegener's granulomatosis and microscopic polyangiitis: a pilot study in 11 patients with renal involvement

1 reference

12 December 2020

An analysis of forty-two Wegener's granulomatosis patients treated with methotrexate and prednisone

1 reference

12 December 2020

Use of a cyclophosphamide-induction methotrexate-maintenance regimen for the treatment of Wegener’s granulomatosis: extended follow-up and rate of relapse

1 reference

12 December 2020

Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab

1 reference

12 December 2020

Rituximab in Churg-Strauss syndrome.

1 reference

12 December 2020

Cytotoxic drugs: their clinical application to the rheumatic diseases

1 reference

12 December 2020

Rituximab and Wegener's granulomatosis: are B cells a target in vasculitis treatment?

1 reference

12 December 2020

Solid malignancies among patients in the Wegener's Granulomatosis Etanercept Trial

1 reference

12 December 2020

Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis

1 reference

12 December 2020

Mycophenolate mofetil for remission maintenance in the treatment of Wegener's granulomatosis

1 reference

12 December 2020

Nine patients with anti-neutrophil cytoplasmic antibody-positive vasculitis successfully treated with rituximab

1 reference

12 December 2020

Leucoencephalopathy after treatment of Churg-Strauss syndrome with interferon {alpha}.

1 reference

12 December 2020

Maintenance of remission with leflunomide in Wegener's granulomatosis

1 reference

12 December 2020

Treatment of subglottic stenosis, due to Wegener's granulomatosis, with intralesional corticosteroids and dilation

1 reference

12 December 2020

Churg-Strauss syndrome

1 reference

12 December 2020

Lack of efficacy of rituximab in Wegener's granulomatosis with refractory granulomatous manifestations

1 reference

12 December 2020

Anti-CD20 therapy of treatment-resistant Wegener's granulomatosis: favourable but temporary response.

1 reference

12 December 2020

Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. Dutch Co-Trimoxazole Wegener Study Group

1 reference

12 December 2020

The value of pulse cyclophosphamide in ANCA-associated vasculitis: meta-analysis and critical review

1 reference

12 December 2020

A pilot study using mycophenolate mofetil in relapsing or resistant ANCA small vessel vasculitis

1 reference

12 December 2020

Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients

1 reference

12 December 2020

Churg Strauss syndrome--successful induction of remission with methotrexate and unexpected high cardiac and pulmonary relapse ratio during maintenance treatment.

1 reference

12 December 2020

A staged approach to the treatment of Wegener's granulomatosis: induction of remission with glucocorticoids and daily cyclophosphamide switching to methotrexate for remission maintenance

1 reference

12 December 2020

Treatment of Wegener's granulomatosis with intermittent high-dose intravenous cyclophosphamide

1 reference

12 December 2020

Wegener's granulomatosis: observations on treatment with antimicrobial agents

1 reference

12 December 2020

High-dose azathioprine pulse therapy as a new treatment option in patients with active Wegener's granulomatosis and lupus nephritis refractory or intolerant to cyclophosphamide

1 reference

12 December 2020

Biological therapies: new treatment options for ANCA-associated vasculitis?

1 reference

12 December 2020

10.1007/S11926-007-0052-8

Identifiers

DOI

1 reference

17 August 2017

1 reference